vs
Side-by-side financial comparison of Huntington Ingalls Industries (HII) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
Huntington Ingalls Industries is the larger business by last-quarter revenue ($1.7B vs $1.1B, roughly 1.5× PERRIGO Co plc). Huntington Ingalls Industries runs the higher net margin — 8.9% vs -127.8%, a 136.8% gap on every dollar of revenue. On growth, Huntington Ingalls Industries posted the faster year-over-year revenue change (13.8% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $-461.0M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -25.2%).
Huntington Ingalls Industries, Inc. (HII) is the largest military shipbuilding company in the United States as well as a provider of professional services to partners in government and industry. HII was formed on 31 March 2011, as a divestiture from Northrop Grumman.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
HII vs PRGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $1.1B |
| Net Profit | $149.0M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 9.3% | -116.0% |
| Net Margin | 8.9% | -127.8% |
| Revenue YoY | 13.8% | -2.5% |
| Net Profit YoY | — | -3093.9% |
| EPS (diluted) | $3.79 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.7B | — | ||
| Q4 25 | $3.5B | $1.1B | ||
| Q3 25 | $3.2B | $1.0B | ||
| Q2 25 | $3.1B | $1.1B | ||
| Q1 25 | $2.7B | $1.0B | ||
| Q4 24 | $3.0B | $1.1B | ||
| Q3 24 | $2.7B | $1.1B | ||
| Q2 24 | $3.0B | $1.1B |
| Q1 26 | $149.0M | — | ||
| Q4 25 | $159.0M | $-1.4B | ||
| Q3 25 | $145.0M | $7.5M | ||
| Q2 25 | $152.0M | $-8.4M | ||
| Q1 25 | $149.0M | $-6.4M | ||
| Q4 24 | $123.0M | $-44.4M | ||
| Q3 24 | $101.0M | $-21.0M | ||
| Q2 24 | $173.0M | $-108.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% |
| Q1 26 | 9.3% | — | ||
| Q4 25 | 4.9% | -116.0% | ||
| Q3 25 | 5.0% | 7.0% | ||
| Q2 25 | 5.3% | 4.3% | ||
| Q1 25 | 5.9% | 4.5% | ||
| Q4 24 | 3.7% | 10.0% | ||
| Q3 24 | 3.0% | 7.4% | ||
| Q2 24 | 6.3% | -2.5% |
| Q1 26 | 8.9% | — | ||
| Q4 25 | 4.6% | -127.8% | ||
| Q3 25 | 4.5% | 0.7% | ||
| Q2 25 | 4.9% | -0.8% | ||
| Q1 25 | 5.4% | -0.6% | ||
| Q4 24 | 4.1% | -3.9% | ||
| Q3 24 | 3.7% | -1.9% | ||
| Q2 24 | 5.8% | -10.2% |
| Q1 26 | $3.79 | — | ||
| Q4 25 | $4.06 | $-10.23 | ||
| Q3 25 | $3.68 | $0.05 | ||
| Q2 25 | $3.86 | $-0.06 | ||
| Q1 25 | $3.79 | $-0.05 | ||
| Q4 24 | $3.15 | $-0.32 | ||
| Q3 24 | $2.56 | $-0.15 | ||
| Q2 24 | $4.38 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $216.0M | — |
| Total DebtLower is stronger | $2.7B | — |
| Stockholders' EquityBook value | $5.1B | $2.9B |
| Total Assets | $12.5B | $8.5B |
| Debt / EquityLower = less leverage | 0.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $216.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $432.1M | ||
| Q2 25 | — | $454.2M | ||
| Q1 25 | — | $409.9M | ||
| Q4 24 | — | $558.8M | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $542.8M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $5.1B | — | ||
| Q4 25 | $5.1B | $2.9B | ||
| Q3 25 | $5.0B | $4.4B | ||
| Q2 25 | $4.9B | $4.5B | ||
| Q1 25 | $4.8B | $4.4B | ||
| Q4 24 | $4.7B | $4.3B | ||
| Q3 24 | $4.2B | $4.6B | ||
| Q2 24 | $4.2B | $4.5B |
| Q1 26 | $12.5B | — | ||
| Q4 25 | $12.7B | $8.5B | ||
| Q3 25 | $12.3B | $10.1B | ||
| Q2 25 | $12.1B | $10.1B | ||
| Q1 25 | $12.1B | $9.8B | ||
| Q4 24 | $12.1B | $9.6B | ||
| Q3 24 | $11.1B | $11.2B | ||
| Q2 24 | $11.3B | $10.4B |
| Q1 26 | 0.52× | — | ||
| Q4 25 | 0.53× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.58× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-390.0M | $175.4M |
| Free Cash FlowOCF − Capex | $-461.0M | $148.6M |
| FCF MarginFCF / Revenue | -27.7% | 13.4% |
| Capex IntensityCapex / Revenue | 4.4% | 2.4% |
| Cash ConversionOCF / Net Profit | -2.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $795.0M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-390.0M | — | ||
| Q4 25 | $650.0M | $175.4M | ||
| Q3 25 | $118.0M | $51.7M | ||
| Q2 25 | $823.0M | $75.9M | ||
| Q1 25 | $-395.0M | $-64.5M | ||
| Q4 24 | $391.0M | $312.6M | ||
| Q3 24 | $213.0M | $42.2M | ||
| Q2 24 | $-9.0M | $9.5M |
| Q1 26 | $-461.0M | — | ||
| Q4 25 | $516.0M | $148.6M | ||
| Q3 25 | $13.0M | $29.8M | ||
| Q2 25 | $727.0M | $56.7M | ||
| Q1 25 | $-462.0M | $-90.0M | ||
| Q4 24 | $277.0M | $274.9M | ||
| Q3 24 | $125.0M | $15.1M | ||
| Q2 24 | $-99.0M | $-18.9M |
| Q1 26 | -27.7% | — | ||
| Q4 25 | 14.8% | 13.4% | ||
| Q3 25 | 0.4% | 2.9% | ||
| Q2 25 | 23.6% | 5.4% | ||
| Q1 25 | -16.9% | -8.6% | ||
| Q4 24 | 9.2% | 24.2% | ||
| Q3 24 | 4.5% | 1.4% | ||
| Q2 24 | -3.3% | -1.8% |
| Q1 26 | 4.4% | — | ||
| Q4 25 | 3.9% | 2.4% | ||
| Q3 25 | 3.3% | 2.1% | ||
| Q2 25 | 3.1% | 1.8% | ||
| Q1 25 | 2.5% | 2.4% | ||
| Q4 24 | 3.8% | 3.3% | ||
| Q3 24 | 3.2% | 2.5% | ||
| Q2 24 | 3.0% | 2.7% |
| Q1 26 | -2.62× | — | ||
| Q4 25 | 4.09× | — | ||
| Q3 25 | 0.81× | 6.89× | ||
| Q2 25 | 5.41× | — | ||
| Q1 25 | -2.65× | — | ||
| Q4 24 | 3.18× | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | -0.05× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HII
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
